Brentuximab vedotin monotherapy is an effective treatment in a frail pediatric patient with Down syndrome and classical Hodgkin lymphoma

被引：1
|
作者：
Vonasek, Julia [1 ]
Edslev, Pernille Wendtland [1 ]
d'Amore, Francesco [2 ]
Hasle, Henrik [1 ]
机构：
[1] Aarhus Univ Hosp, Dept Pediat & Adolescent Hlth, Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Hematol, Aarhus, Denmark
来源：
PEDIATRIC BLOOD & CANCER | 2020年 / 67卷 / 02期
关键词：
D O I：
10.1002/pbc.28082
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Frontline brentuximab vedotin as monotherapy or in combination for older Hodgkin lymphoma patients.
    Yasenchak, Christopher A.
    Bordoni, Rodolfo Eduardo
    Patel-Donnelly, Dipti
    Larson, Tim
    Goldschmidt, Jerome H.
    Boccia, Ralph, V
    Cline, Vivian Jean M.
    Forero-Torres, Andres
    Sims, Robert Brownell
    Newhook, Trevor
    Friedberg, Jonathan W.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] Brentuximab vedotin desensitization in a patient with refractory Hodgkin's lymphoma
    Arora, Anubha
    Bhatt, Vijaya Raj
    Liewer, Susanne
    Armitage, James O.
    Bociek, R. Gregory
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 95 (04) : 361 - 364
  • [23] Brentuximab Vedotin Plus Bendamustine Is an Effective Salvage Regimen for Pediatric Patients with Relapsed Hodgkin Lymphoma
    Gulati, Nitya
    Boulad, Farid
    Cancio, Maria I.
    Curran, Kevin J.
    Jackson, Carolyn
    Kernan, Nancy
    Kung, Andrew L.
    O'Reilly, Richard
    Prockop, Susan
    Ramaswamy, Kavitha
    Scaradavou, Andromachi
    Spitzer, Barbara
    Shukla, Neerav
    Steinherz, Peter G.
    Forlenza, Christopher
    BLOOD, 2017, 130
  • [24] Brentuximab vedotin is effective for rheumatoid arthritis in a patient with relapsed methotrexate-associated Hodgkin lymphoma
    Tomonori Nakazato
    Satoshi Takanashi
    Motoharu Hirano
    Chisako Ito
    Yuriko Fujita
    Yuki Osada
    Yoshinobu Aisa
    Takehiko Mori
    Annals of Hematology, 2018, 97 : 1489 - 1491
  • [25] Brentuximab vedotin is effective for rheumatoid arthritis in a patient with relapsed methotrexate-associated Hodgkin lymphoma
    Nakazato, Tomonori
    Takanashi, Satoshi
    Hirano, Motoharu
    Ito, Chisako
    Fujita, Yuriko
    Osada, Yuki
    Aisa, Yoshinobu
    Mori, Takehiko
    ANNALS OF HEMATOLOGY, 2018, 97 (08) : 1489 - 1491
  • [26] Safety and Efficacy of Brentuximab Vedotin in the Treatment of Classic Hodgkin Lymphoma
    Makita, Shinichi
    Maruyama, Dai
    Tobinai, Kensei
    ONCOTARGETS AND THERAPY, 2020, 13 : 5993 - 6009
  • [27] Role of brentuximab vedotin in the treatment of relapsed or refractory Hodgkin lymphoma
    Siddiqi, Tanya
    Thomas, Sandra H.
    Chen, Robert
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2014, 7 : 79 - 85
  • [28] Brentuximab vedotin treatment in patients with relapsed or refractory Hodgkin lymphoma
    Zsuzsa, Molnar
    Imre, Pinczes Laszlo
    Klara, Piukovics
    Ildiko, Istenes
    Krisztina, Wolf
    Zoltan, Csukly
    Arpad, Szomor
    Arpad, Illes
    Zsofia, Miltenyi
    ORVOSI HETILAP, 2017, 158 (41) : 1630 - 1634
  • [29] BRENTUXIMAB VEDOTIN MAY CUT RADIATION USE IN PEDIATRIC HODGKIN LYMPHOMA
    不详
    CANCER DISCOVERY, 2021, 11 (06) : 1318 - 1318
  • [30] Successful brentuximab vedotin monotherapy against late relapse of classical Hodgkin lymphoma 6 years after first remission
    Nagashima, Kana
    Kikuchi, Shohei
    Iyama, Satoshi
    Fujita, Chisa
    Goto, Akari
    Horiguchi, Hiroto
    Kobune, Masayoshi
    CLINICAL CASE REPORTS, 2020, 8 (03): : 466 - 468
12345